Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Optibrium appoints Ian Smith as Chief Technology Officer

Optibrium appoints Ian Smith as Chief Technology Officer

Scientists develop RNA-targeting strategy to repair genetic cause of ALS and dementia

Scientists develop RNA-targeting strategy to repair genetic cause of ALS and dementia

Cancer Research Horizons, Newcastle University extend strategic drug discovery alliance with Astex Pharmaceuticals

Cancer Research Horizons, Newcastle University extend strategic drug discovery alliance with Astex Pharmaceuticals

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

NIAID awards more than $12 million for the development of antiviral therapies

NIAID awards more than $12 million for the development of antiviral therapies

Scientists identify a class of drugs that may prevent alcohol use disorder in people with PTSD

Scientists identify a class of drugs that may prevent alcohol use disorder in people with PTSD

Researchers to develop brain imaging radiotracers for better understanding of Alzheimer's, autism

Researchers to develop brain imaging radiotracers for better understanding of Alzheimer's, autism

Molecular motion of many 'undruggable' proteins reveals previously unseen binding sites

Molecular motion of many 'undruggable' proteins reveals previously unseen binding sites

New Community of Experts launched to harness social media data for patient-centric drug development

New Community of Experts launched to harness social media data for patient-centric drug development

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Sanford Burnham Prebys researchers receive ACS grants to advance work on difficult-to-treat cancers

Sanford Burnham Prebys researchers receive ACS grants to advance work on difficult-to-treat cancers

Behind the Scenes of the Oncology & Precision Medicine Conferences 2022

Behind the Scenes of the Oncology & Precision Medicine Conferences 2022

New fentanyl vaccine could prevent deadly opioid from entering the brain

New fentanyl vaccine could prevent deadly opioid from entering the brain

PALS program effective in ensuring diverse representation in lupus clinical trials

PALS program effective in ensuring diverse representation in lupus clinical trials

Harnessing the natural potential of venom for drug discovery

Harnessing the natural potential of venom for drug discovery

Cancer Research Horizons: The Innovation Engine of Cancer Research UK

Cancer Research Horizons: The Innovation Engine of Cancer Research UK

ELRIG: Bringing Life Sciences and Drug Discovery Communities Together

ELRIG: Bringing Life Sciences and Drug Discovery Communities Together

New approach can help design shorter, more powerful trials to assess Parkinson’s drugs

New approach can help design shorter, more powerful trials to assess Parkinson’s drugs

EVIDENT and Ultivue collaborate to advance multiplex slide imaging and spatial analysis in translational research

EVIDENT and Ultivue collaborate to advance multiplex slide imaging and spatial analysis in translational research